Differences Between Vitamin K2 MK-4 and MK-7 and Guide to End-Use Applications

Table of Content [Hide]

As a core nutrient for bone health and cardiovascular support, Vitamin K2 has two major subtypes widely used in commercial applications: MK-4 (menaquinone-4) and MK-7 (menaquinone-7). Due to differences in their molecular structures, they have distinct focuses in absorption, metabolism, and application scenarios. This article will analyze the core differences between the two and provide selection suggestions based on end-product needs, assisting in health product R&D and consumption decisions.

I. Core Differences Between MK-4 and MK-7

The essential difference between MK-4 and MK-7 lies in the number of isoprene units in their side chains (4 vs. 7), which directly determines their absorption, efficacy duration, and cost characteristics. The following is a comparison of key dimensions for quick differentiation:

Comparison Dimension	Vitamin K2 MK-4	Vitamin K2 MK-7
Molecular Structure	Short-chain type (4 isoprene units)	Long-chain type (7 isoprene units)
Main Sources	Chemical synthesis (mainstream), animal sources (dairy products, egg yolks, animal livers)	Microbial fermentation (mainly natto bacteria, mainstream for natural products), chemical synthesis (niche)
Absorption Characteristics	Direct absorption in the upper small intestine, no need for bile salt emulsification, fast absorption rate	Absorption throughout the small intestine, requiring bile salt emulsification, slow but more complete absorption
Bioavailability	Low, limited retention rate in the body at the same dosage	High, microgram-level dosage can reach effective plasma concentration, several times that of MK-4
Efficacy Duration	Half-life of 1-2 hours, rapid fluctuations in plasma concentration, requiring frequent supplementation	Half-life of 72 hours, stable plasma concentration, long-term maintenance of supportive effects
Daily Supplementary Dosage	Milligram-level (mg), 15-45mg/day for daily maintenance	Microgram-level (μg), 100-200μg/day for daily maintenance
Supplementation Frequency	2-3 times a day to maintain effective concentration	Once a day, suitable for convenient health needs
Commercial Cost	Low cost for chemically synthesized products, excellent cost-performance ratio	Medium-high cost for fermented products (premium for natural selling points), cost of synthetic products close to MK-4
Stability	Moderate stability to light, heat, and oxygen, requiring encapsulation protection	Excellent stability, no special protection needed for conventional formulations, long shelf life

Supplementary Highlight: Core Commonality Between the Two

Despite obvious differences, MK-4 and MK-7 share the same core physiological functions: both promote targeted calcium deposition, inhibit vascular calcium deposition, and are widely used in bone health and cardiovascular support products. They only differ in efficacy efficiency and scenario adaptability.

II. Core Strategies for End-Product Selection

The core of selection is to match product positioning, target groups, and formulation design, rather than simply judging advantages and disadvantages. The following provides clear suggestions based on three major scenarios, covering most end-use needs.

1. Selection by Product Formulation and Supplementation Frequency

Prefer MK-4: For formulations such as oral liquids, instant powders, and uncoated chewable tablets, leverage its "fast absorption" feature to create a "rapid-acting support" selling point; also suitable for daily multi-dose sachet and packaged products, controlling pricing with low costs.
Prefer MK-7: For formulations such as hard capsules, soft capsules, and sustained-release compressed candies, highlight the convenience of "one capsule a day, long-term care" to cater to the modern lazy health trend; MK-7 is also preferred for large-volume bottled products, reducing production losses with high stability.

2. Selection by Target Group

Prefer MK-4: People with weak gastrointestinal absorption capacity (e.g., middle-aged and elderly individuals, those with poor digestive function) – its bile salt-independent absorption avoids nutrient loss; general consumers pursuing high cost-performance, suitable for affordable products in sinking markets.
Prefer MK-7: Healthy adults aged 25+, seeking convenience for daily basic maintenance; middle-aged and elderly individuals aged 50+, in need of long-term stable nutrient supply for maintenance; high-end consumers, as the "natural natto source" selling point of fermented MK-7 is more in line with their needs; busy urban populations, as once-daily frequency reduces missed doses.

3. Selection by Product Positioning and Selling Points

Prefer MK-4: Affordable mass-market products, focusing on "cost-effective basic maintenance" with pricing controlled at $0.3-$1.3 per bottle; gastrointestinal-friendly products, targeting the niche selling point of "suitable for weak digestive systems" to accurately cover specific needs.
Prefer MK-7: Mid-to-high-end health products, focusing on "natural fermentation, long-term care" with pricing at $2-$6.6 per bottle, suitable for the online high-end health consumer market; compound formulations (combined with calcium, vitamin D3, and magnesium), leveraging the convenience of "one dose a day" to create a "one-stop bone health solution," currently the mainstream in the market; cardiovascular support niche products, as MK-7’s long-term plasma concentration is more beneficial for daily vascular care.

High-End Upgrade: MK-4 + MK-7 Combination Scheme

For high-end full-effect bone health products, the "MK-4 rapid-acting + MK-7 long-acting" combination can be adopted to create a differentiated selling point of "dual-effect care, all-day coverage," suitable for high-priced products ($6.6-$13 per bottle).

Recommended ratio: MK-4 (5-10mg) + MK-7 (100-200μg) per day, balancing rapid onset and sustained maintenance, suitable for high-end groups with dual needs for bone and cardiovascular support.

III. Tips for Avoiding Pitfalls in End-Use Applications

Do not mismatch dosages: Do not add MK-7 at MK-4’s milligram-level dosage (wasting costs), nor add MK-4 at MK-7’s microgram-level dosage (failing to achieve maintenance effects).
Selling points must match raw materials: Products claiming "natural fermentation" must use fermented MK-7, accompanied by natto bacteria fermentation test reports to avoid false advertising.
Optimize absorption adaptability: When selecting MK-7 for products targeting the middle-aged and elderly, add bile salt extracts or prebiotics to improve absorption efficiency.
Ensure stability protection: When using MK-4 in oral liquids or liquid beverages, conduct microencapsulation treatment (e.g., cyclodextrin encapsulation) to prevent decomposition and inactivation.

IV. Summary: Core Selection Rhyme

1. For rapid effect, weak gastrointestinal function, affordability, and multi-dose frequency → Choose MK-4; 2. For long-term effect, high bioavailability, high-end positioning, and convenience → Choose MK-7; 3. For full-effect coverage, high-end compounding, and dual bone-cardiovascular support → Choose MK-4 + MK-7 combination.

Currently, MK-7 accounts for over 80% of the end-market due to its convenience and natural selling points, becoming the mainstream choice; MK-4 occupies the niche market with its low cost and adaptability to groups with weak digestion. Both can maximize their value when accurately matching product needs.

References

NMNH Raw Material Terminal Application Matching Guide and Supply Solutions

This is the last one.